Strategies for early detection of lung cancer

Clinical Pulmonary Medicine

Volumn 6, Issue 1, 1999, Pages 66-72

  Saraceno, Joseph ^a   Spivack, Simon D ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Biomarkers; Disease detection; Lung cancer; Screening; Susceptibility

Indexed keywords

BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FAMILY HISTORY; GENETIC RISK; HIGH RISK PATIENT; HUMAN; LUNG CANCER; LUNG LAVAGE; REVIEW; SMOKING; SMOKING CESSATION; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY;

EID: 0033039606     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199901000-00007     Document Type: Review

References (50)

1. National Cancer Institute. SEER cancer statistics 1973-1994. Available at: http://www-seer.ims.nci.nih.gov/ (accessed January 16, 1998).
2. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer: a critique of the Mayo lung project. Cancer 1991;67:1155-64.
3. Wolpaw DR. Early detection in lung cancer. Med Clin North Am 1996;80:63-82.
4. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer: another look, a different view. Chest 1997;111:754-68.
5. Shaw CL, Falk RT, Pickle LW, Mason TJ, Buffler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 1991;44:429-37.
6. McDuffie HH. Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 1991;44:69-76.
7. Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;2:217-22.
8. Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1986;134: 466-70.
9. Tockman MS, Anthonisen NR, Wright EC, Donithn MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987;106: 512-8.
10. Griffen JP. Interstitial pulmonary fibrosis and lung cancer. Chest 1995;108:1193-4.
11. Wells C, Mannino DM. Pulmonary fibrosis and lung cancer in the U.S. South Med J 1996; 89:505-10.
12. Kvale G, Bjelke E, Gatt JJ. Dietary habits and lung cancer risk. Int J Cancer 1983;31:397-405.
13. Groeger AM, Mueller MR, Odocha O, et al. Ethnic variations in lung cancer. Anticancer Res 1997;17:2849-57.
14. Ries LAG, Hankey BF, Miller BA, Hartman AM, Edwards BK. Cancer statistics review 1973-88. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1991. NIH Publication No. 91-2789.
15. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The molecular epidemiology of lung cancer. Crit Rev Toxicol 1997;27:319-65.
16. Birrer MJ, Brown PH. Application of molecular genetics to the early diagnosis and screening of lung cancer. Cancer Res 1992;52(9 Suppl):2658S-2664S.
17. Hasday JD, McCrea KA. Inherited predisposition to lung cancer. Occup Med 1992;7:227-40.
18. Strauss GM, Gleason RE, Sugarbaker DJ. Screening for lung cancer. Chest 1997;111:754-68.
19. Wolpaw DR. Early detection in lung cancer. Med Clin North Am 1996;80:63-80.
20. Soda H, Hiroshi T, Kohno S, Oka M. Limitation of annual screening chest radiography for the diagnosis of lung cancer. Cancer 1993;72: 2341-5.
21. Flehinger BJ, Kimmel M, Melamed MR. Natural history of adenocarcinoma-large cell carcinoma of the lung. Conclusions from screening programs in New York and Baltimore. J Natl Cancer Inst 1988;80:337-44.
22. Lilienfeld A, Archer PG, Burnett CH, et al. An evaluation of radiologic and cytologic screening for early detection of lung cancer: a cooperative pilot study of the American Cancer Society and the Veterans Administration. Cancer Res 1966;26:2083-121.
23. Eddy DM. Screening for lung cancer. Ann Intern Med 1989;111:232-7.
24. Marfin AA, Schenker M. Screening for lung cancer: effective tests awaiting effective treatment. Occup Med 1991;6:111-31.
25. Gelmann EP, Reding D, Buys S, et al., PLCO investigators. Prostate, lung, colorectal, and ovarian cancer screening trial (PLCO trial) [abstract]. Proc Annu Meet Am Soc Clin Oncol 1997;16:A1492.
26. American Cancer Society. 1989 survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 1990;40:77-101.
27. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256-70.
28. Gledhill A, Bates C, Henderson D, DaCosta P, Thomas G. Sputum cytology: a limited role. J Clin Pathol 1997;50:566-8.
29. Strauss GM, Skarin AT. Use of tumor markers in lung cancer. Hematol Oncol Clin North Am 1994;8:507-82.
30. Gail MH, Muenz L, McIntire KR, et al. Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. J Natl Cancer Inst 1988;80:97-101.
31. Johnson BE, Kelly MJ. Overview of genetic and molecular events in the pathogenesis of lung cancer. Chest 1993;103(1 Suppl):1S-3S.
32. Ronai Z, Yabubovskaya MS, Zhang E, Belitsky GA. K-ras mutation in sputum of patients with or without lung cancer. J Cell Biochem Suppl 1996;25:172-6.
33. Lehman TA, Scott F, Seddon M, et al. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction. Anal Biochem 1996;239:153-9.
34. Szabo E, Birrer MJ, Mulshine JL. Early detection of lung cancer. Semin Oncol 1993;20:374-82.
35. Bennet WP, Colby TV, Davis WD, et al. p53 Protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993;53:4817-22.
36. Hirano T, Franzen B, Kato H, Ebihara Y, Auer G. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol 1994; 144:296-302.
37. Tockman MS. Clinical detection of lung cancer progression markers. J Cell Biochem Suppl 1997;25:177-84.
38. Tockman MS, Gupta PK, Myers JD, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988;6: 1685-93.
39. Tockman MS, Erozan YS, Gupta P, Piantadosi S, Mulshine JL, Ruckdeschel JC. The early detection of second primary lung cancers by sputum immunostaining. Chest 1994;106(6 Suppl):385S-390S.
40. Payne PW, Sebo TJ, Doudkine A, et al. Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clin Proc 1997;72:697-704.
41. Lam S, MacAulay C, Palcic B. Detection and localization of early lung cancer by imaging techniques. Chest 1993;103(1 Suppl):12S-14S.
42. Nakhosteen JA, Khanavkar B, Multi A, et al. Early detection of bronchial carcinoma with autofluorescence LIFE bronchoscopy and automated sputum cytometry: the next generation. J Diagn Ther 1997;23:211-7 (English translation).
43. Venmans BJW, Boxem AJM, Postmus PE, et al. Sensitivity of fluorescence bronchoscopy in clinical practice [abstract]. International Meeting on Respiratory Endoscopy, Sitges, Spain, 1997.
44. Yokomise H, Yanagihara K, Fukuse T, et al. Clinical experience with lung-imaging fluorescence endoscope (LIFE) in patients with lung cancer. J Bronchol 1997;4:205-8.
45. Kennedy T, Miller Y, Cook R, et al. Fluorescence bronchoscopy compared to white light bronchoscopy in the detection of high grade dysplasia or worse in subjects with abnormal sputum cytology or with known or suspected lung cancer [abstract]. Presented at the National Cancer Institute SPORE Meeting, Washington, DC, July 1997.
46. Kennedy T, Miller Y, Proudfoot S, et al. Histopathologic findings from abnormally fluorescent endobronchial areas in subjects with moderate dysplasia or worse on sputum cytology [abstract]. Presented at the National Cancer Institute SPORE Meeting, Washington, DC, July 1997.
47. Ikeda N, Kim K, Okunaka T, et al. Early localization of bronchogenic cancerous/precancerous lesions with lung imaging fluorescence endoscope (LIFE). Diagn Ther Endosc 1997;3: 197-201.
48. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
49. Swensen SJ, Brown LR, Colby TV, Weaver AL. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995;194:393-8.
50. Dewan NA. When to consider FDG-PET imaging on solitary pulmonary nodules. Clin Pulm Med 1997;4:344-50.